Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
CALL
Rhythm Pharmaceuticals
RYTM
$7.96B
| $230K | ﹤0.01% |
5,600
| – | – |
|
3377
Digimarc Corp
DMRC
$178M
| $229K | ﹤0.01% |
7,384
-5,397
| -42% | -$137K |
|
3378
MVB Financial
MVBF
$389M
| $228K | ﹤0.01% |
12,246
-3,972
| -24% | -$75.7K |
|
3379
Zymeworks
ZYME
$1.67B
| $228K | ﹤0.01% |
26,789
-21,515
| -45% | -$192K |
|
|
TDAY
3380
USA Today Co
TDAY
$1.06B
| $227K | ﹤0.01% |
49,345
-165,114
| -77% | -$552K |
|
|
LAR
3381
Lithium Argentina AG
LAR
$1.14B
| $227K | ﹤0.01% |
71,050
-27,960
| -28% | -$132K |
|
3382
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.77B
| $227K | ﹤0.01% |
3,152
| – | – |
|
3383
Stagwell
STGW
$2.24B
| $227K | ﹤0.01% |
33,220
-43,207
| -57% | -$279K |
|
3384
Nektar Therapeutics
NKTR
$2.58B
| $227K | ﹤0.01% |
12,180
-26,018
| -68% | -$548K |
|
3385
Invesco Semiconductors ETF
PSI
$2.5B
| $226K | ﹤0.01% |
3,591
| – | – |
|
3386
Vanguard Total World Stock ETF
VT
$79.8B
| $225K | ﹤0.01% |
2,000
| – | – |
|
3387
LSB Industries
LXU
$693M
| $225K | ﹤0.01% |
27,480
-36,755
| -57% | -$321K |
|
|
BCOV
3388
DELISTED
Brightcove, Inc.
BCOV
| $225K | ﹤0.01% |
94,768
-19,652
| -17% | -$38.6K |
|
3389
Nice
NICE
$5.97B
| $225K | ﹤0.01% |
1,306
-6,598
| -83% | -$1.36M |
|
3390
Lands' End
LE
$403M
| $223K | ﹤0.01% |
16,420
-5,039
| -23% | -$67.8K |
|
3391
Vanguard Morningstar Mid-Cap ETF
VO
$109B
| $222K | ﹤0.01% |
3,668
| – | – |
|
|
TGAAW
3392
DELISTED
Target Global Acquisition I Corp. Warrant
TGAAW
| $222K | ﹤0.01% |
19,548
| – | – |
|
3393
Viant Technology
DSP
$265M
| $222K | ﹤0.01% |
22,471
-5,113
| -19% | -$47.7K |
|
3394
LendingTree
TREE
$451M
| $222K | ﹤0.01% |
5,332
-2,103
| -28% | -$88.7K |
|
3395
MainStreet Bancshares
MNSB
$172M
| $222K | ﹤0.01% |
12,503
-451
| -3% | -$7.6K |
|
3396
Ribbon Communications
RBBN
$383M
| $221K | ﹤0.01% |
67,141
-47,744
| -42% | -$145K |
|
|
LAZR
3397
DELISTED
Luminar Technologies
LAZR
| $220K | ﹤0.01% |
9,865
-13,397
| -58% | -$317K |
|
3398
Vitesse Energy
VTS
$665M
| $220K | ﹤0.01% |
9,285
-12,888
| -58% | -$306K |
|
3399
Dianthus Therapeutics
DNTH
$6.09B
| $220K | ﹤0.01% |
8,499
-5,904
| -41% | -$142K |
|
|
RAPP
3400
Rapport Therapeutics
RAPP
$2.18B
| $219K | ﹤0.01% |
+9,400
| New | +$218K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.